beta

AIMT

Aimmune Therapeutics Inc.

Aimt

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Aimmune Therapeutics Inc is engaged in the field of biotechnology. It researches and develops drug candidates for the treatment of peanut and other food allergies.

Market Cap: 1.91 Billion

Primary Exchange: Nasdaq Global Select

Website: http://www.aimmune.com

Shares Outstanding: 51.2 Million

Float: 50.4 Million

Dividend: 0.0 (0.0%)

Beta: -0.77665

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 2.62 Million

Ethical Flags

Animal testing

Longest drawdown: 971 trading days

From: 2017-12-22 To: 2019-10-18

Lowest Point:

Aimmune to Present at the JMP Securities Life Sciences Conference

via: Business Wire at 2019-06-12 04:00:00:000

Aimmune Therapeutics, Inc.(Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that its President and Chief Executive Officer, Jayson Dallas, M.D., will present at the JMP Securities Life Sciences Conference on Wednesday… read more...

Aimmune to Present at the JMP Securities Life Sciences Conference

via: Business Wire at 2019-06-12 04:00:00:000

Aimmune Therapeutics, Inc.(Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that its President and Chief Executive Officer, Jayson Dallas, M.D., will present at the JMP Securities Life Sciences Conference on Wednesday… read more...

Aimmune Therapeutics Discusses AR101's Cost-Effectiveness and Demonstrated Clinical Benefits at ICER Meeting

via: Business Wire at 2019-06-11 04:00:00:000

Company to Share Updated Clinical Data on AR101 and Provide Perspective on Its Value to Society Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, will present at the Institute for Clinical and Economic … read more...

Chewy IPO, Lululemon And Tesla On Tap (Stocks To Watch Podcast)

via: SeekingAlpha at 2019-06-09 03:30:00:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks.. If you are interested in listening to Stocks To Watch to start your Sunday (you can r… read more...

Chewy IPO, Lululemon And Tesla On Tap (Stocks To Watch Podcast)

via: SeekingAlpha at 2019-06-09 03:30:00:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks.. If you are interested in listening to Stocks To Watch to start your Sunday (you can r… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud